Nervonik is a medical device company developing an opioid-free peripheral nerve stimulation (PNS) system.
Nervonik has raised $52.5M in total funding. The most recent round was Series B. The last funding was announced in April 2026.
Nervonik's investors include U.S. Venture Partners, Lumira Ventures, Foothill Ventures, Correlation Ventures, Elevage Medical Technologies.
Nervonik is headquartered in Los Angeles, United States.
Nervonik is a medical device company developing an opioid-free peripheral nerve stimulation (PNS) system.
Nervonik is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nervonik — Funding & Investors." VCBacked, April 27, 2026, https://www.vcbacked.co/company/nervonik. Accessed October 21, 2026.
VCBacked. (2026). Nervonik — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/nervonik
{{cite web |title=Nervonik — Funding & Investors |url=https://www.vcbacked.co/company/nervonik |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated